AP2006003759A0 - (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazoloÄ1,5-cÜÄ1,3Übenzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors - Google Patents

(1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazoloÄ1,5-cÜÄ1,3Übenzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors

Info

Publication number
AP2006003759A0
AP2006003759A0 AP2006003759A AP2006003759A AP2006003759A0 AP 2006003759 A0 AP2006003759 A0 AP 2006003759A0 AP 2006003759 A AP2006003759 A AP 2006003759A AP 2006003759 A AP2006003759 A AP 2006003759A AP 2006003759 A0 AP2006003759 A0 AP 2006003759A0
Authority
AP
ARIPO
Prior art keywords
phenyl
cüä1
aminocarbonyl
dihydro
viral replication
Prior art date
Application number
AP2006003759A
Other languages
English (en)
Inventor
Abdellah Tahri
Lieve Emma Jan Michiels
Dominique Louis Nest Surleraux
Van Koenraad Lodewijk Au Acker
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of AP2006003759A0 publication Critical patent/AP2006003759A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AP2006003759A 2004-05-04 2005-05-04 (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazoloÄ1,5-cÜÄ1,3Übenzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors AP2006003759A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04101913 2004-05-04
US60427504P 2004-08-25 2004-08-25
PCT/EP2005/052041 WO2005105810A2 (en) 2004-05-04 2005-05-04 (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazolo[1,5- c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as hiv viral replication inhibitors

Publications (1)

Publication Number Publication Date
AP2006003759A0 true AP2006003759A0 (en) 2006-10-31

Family

ID=35058129

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2006003759A AP2006003759A0 (en) 2004-05-04 2005-05-04 (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazoloÄ1,5-cÜÄ1,3Übenzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors

Country Status (20)

Country Link
US (1) US7326703B2 (de)
EP (1) EP1778696B1 (de)
JP (1) JP4929162B2 (de)
KR (1) KR20070015547A (de)
CN (1) CN1950380B (de)
AP (1) AP2006003759A0 (de)
AR (1) AR048650A1 (de)
AT (1) ATE389660T1 (de)
AU (1) AU2005238235B2 (de)
BR (1) BRPI0510612A (de)
CA (1) CA2563959C (de)
DE (1) DE602005005490T2 (de)
ES (1) ES2303244T3 (de)
IL (1) IL178082A (de)
MX (1) MXPA06012755A (de)
NO (1) NO20065582L (de)
PL (1) PL1778696T3 (de)
RU (1) RU2382789C2 (de)
WO (1) WO2005105810A2 (de)
ZA (1) ZA200609178B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7122185B2 (en) 2002-02-22 2006-10-17 Progenics Pharmaceuticals, Inc. Anti-CCR5 antibody
AR056652A1 (es) * 2005-04-11 2007-10-17 Tibotec Pharm Ltd Derivados de (1,10-b dihidro-2-(aminoalquil-fenil) -5h-pirazolo (1,5-c) (1,3)benzoxazin-5-il) fenilmetanona y su uso en la fabricacion de un medicamento
KR20080035653A (ko) * 2005-07-22 2008-04-23 프로제닉스 파머슈티컬스, 인코포레이티드 Ｈｉｖ―１ 감염 환자에서 바이러스 부하를 감소시키는방법
CN101790371A (zh) * 2007-06-25 2010-07-28 泰博特克药品公司 包含达芦那韦和依曲韦林的组合制剂
US8592487B2 (en) * 2007-10-26 2013-11-26 Concert Pharmaceuticals, Inc. Deuterated darunavir
WO2009134401A2 (en) * 2008-04-29 2009-11-05 Progenics Pharmaceuticals, Inc. Methods of inhibiting infection by diverse subtypes of drug-resistant hiv-1

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
DE4210939A1 (de) * 1992-04-02 1993-10-07 Bayer Ag Verwendung von 7-Oxo-7H-pyrido[1,2,3-de][1,4]benzoxacin-6-carbonsäuren und -estern als Arzneimittel
IL106507A (en) * 1992-08-07 1997-11-20 Merck & Co Inc Pharmaceutical compositions containing benzoxazinones and some novel compounds of this type
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
SK283569B6 (sk) 1993-10-01 2003-09-11 Astra Aktiebolag Spôsob spracovania jemne deleného práškového liečiva, zariadenie na vykonávanie tohto spôsobu a aglomeráty vyrobené týmto spôsobom
DK0904060T3 (da) 1996-05-20 2004-04-13 Janssen Pharmaceutica Nv Antifungale præparater med forbedret biotilgængelighed
WO1998014436A1 (en) * 1996-10-02 1998-04-09 Dupont Pharmaceuticals Company 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same
WO1998042318A1 (en) 1997-03-26 1998-10-01 Janssen Pharmaceutica N.V. Pellets having a core coated with an antifungal and a polymer
KR20010025055A (ko) * 1998-05-20 2001-03-26 피터 지. 스트링거 항바이러스 화합물
EE05400B1 (et) * 2001-04-10 2011-04-15 Pfizer Inc. Prasoolderivaadid, neid v?i nende farmatseutiliselt vastuv?etavaid sooli, solvaate v?i derivaate sisaldavad farmatseutilised kompositsioonid, nende kasutamine ning meetodid nende valmistamiseks

Also Published As

Publication number Publication date
BRPI0510612A (pt) 2007-10-30
PL1778696T3 (pl) 2008-08-29
AU2005238235A1 (en) 2005-11-10
US7326703B2 (en) 2008-02-05
ES2303244T3 (es) 2008-08-01
EP1778696B1 (de) 2008-03-19
IL178082A (en) 2012-06-28
DE602005005490D1 (de) 2008-04-30
KR20070015547A (ko) 2007-02-05
RU2006142705A (ru) 2008-06-20
WO2005105810A3 (en) 2006-03-02
AR048650A1 (es) 2006-05-10
WO2005105810A2 (en) 2005-11-10
ZA200609178B (en) 2008-08-27
RU2382789C2 (ru) 2010-02-27
CA2563959A1 (en) 2005-11-10
ATE389660T1 (de) 2008-04-15
AU2005238235B2 (en) 2011-07-07
CA2563959C (en) 2014-07-15
EP1778696A2 (de) 2007-05-02
JP2007536346A (ja) 2007-12-13
JP4929162B2 (ja) 2012-05-09
CN1950380A (zh) 2007-04-18
CN1950380B (zh) 2010-12-08
US20070248624A1 (en) 2007-10-25
MXPA06012755A (es) 2007-01-16
DE602005005490T2 (de) 2009-04-23
NO20065582L (no) 2006-12-04
IL178082A0 (en) 2006-12-31

Similar Documents

Publication Publication Date Title
IL183706A0 (en) 2,4(4,6) pyrimidine derivatives
AP2005003452A0 (en) Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors.
AP2005003353A0 (en) Diazepinoindole derivatives as kinase inhibitors.
DK1711494T3 (da) Arylsubstituerede heterocykler, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
AP2006003517A0 (en) Hiv replication purine derivatives.
PT1751111E (pt) Derivados de 1,2,3,4-tetrahidroisoquinolina substituída
ZA200804489B (en) 1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as PTP-AS inhibitors
GB0419481D0 (en) Isoindolin-1-one derivatives
ZA200700351B (en) Compounds, compositions and methods
IL192298A (en) Heterocyclic Compounds, Their Acceptable Salts, Pharmaceuticals Containing and Using Them
AP2006003659A0 (en) Azabenzofuran substituted thioureas, inhibitors ofviral replication
IL183568A (en) Process for making 7,8-dihydro-5 h-patridine-6-onh
TW200724540A (en) Heterocyclic antiviral compounds
AP2321A (en) Quinoline derivatives for use as mycobactrial inhibitor.
EP2223921B8 (de) 2-Thiophen-2-yl-oxazol-, 2-Thiophen-2-yl-thiazol- und 2-Thiophen-2-yl-1H-imidazol-Derivate als antivirale Wirkstoffe
IL182054A0 (en) Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors
ZA200805028B (en) Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor Xla inhibitors
IL182538A0 (en) 1,5-diheterocycle-1h-triazole derivative
IL179068A0 (en) Substituted enaminones, their derivatives and uses thereof
IL178082A0 (en) (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazolo[1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as hiv viral replication inhibitors
ATE445604T1 (de) Neue 2,6-diaminopyridin-3-on-derivate
GB0400717D0 (en) Ferrocene derivatives
AP2006003487A0 (en) Substituted arylthiourea derivatives useful as inhibitors of viral replication.
EP1798269A4 (de) Oxidativ polymerisierbare masse
GB0327133D0 (en) Viral replication